A meta-analysis of methylprednisolone in recovery from multiple sclerosis exacerbations

Multiple Sclerosis

Volumn 6, Issue 4, 2000, Pages 267-273

  Miller, D M ^a   Weinstock Guttman, B ^a   Bethoux, F ^a   Lee, J C ^a   Beck, G ^a   Block, V ^a   Durelli, L ^a   LaMantia, L ^a   Barnes, D ^a   Sellebjerg, F ^a   Rudick, R A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Meta analysis; Methylprednisolone; Multiple sclerosis

Indexed keywords

GLUCOCORTICOID; METHYLPREDNISOLONE; PREDNISONE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; HEALTH CARE COST; HUMAN; META ANALYSIS; MULTIPLE SCLEROSIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT PLANNING;

EID: 0033838819     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/135245800678827770     Document Type: Article

References (21)

1. Revised estimates of the prevalence of multiple sclerosis in the United States
2. The natural history of multiple sclerosis: A geographically based study. I. Clinical course and disability
3. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)
4. Interferon beta-1b in the treatment of multiple sclerosis: Final outcome of the randomized controlled trial
5. Treatment of multiple sclerosis with ACTH and corticosteroids
6. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
7. Some statistical methods for combining experimental results
8. Meta-analysis in clinical trials
9. High-dose intravenous methyl-prednisolone in the treatment of multiple sclerosis: Clinical-immunologic correlations
10. A double-blind controlled trial of high dose methylprednisolome in patients with multiple sclerosis: 1. Clinical effects
11. Double-blind, randomized, placebo-controlled study of oral, high-dose methylprednisolone in attacks of MS
12. Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis
13. Double-blind trial of dexamethasone versus methylprednisolone in multiple sclerosis acute relapses
14. Double-blind randomized trial of ACTH versus dexamethasone versus methylprednisolone in multiple sclerosis bouts. Clinical, cerebrospinal fluid and neurophysiological results
15. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group
16. Methylprednisolone in multiple sclerosis: A comparison of oral with intravenous therapy at equivalent high dose
17. Relative efficacy of intravenous methylprednisolone and ACTH in the treatment of acute relapse in MS
18. A randomized, controlled trial of oral high-dose methylprednisolone in acute optic neuritis